Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 11/20 | 0.43 |
| ▸ | FPR1 | P21462 | 10/20 | 0.43 |
| ▸ | KDM1A | O60341 | 2/20 | 0.41 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.39 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.39 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18578803 | 0.85 | FPR2 (0.58) | FPR2FPR1PDE4APDE4BPDE4C | |
| SCHEMBL29434310 | 0.85 | FPR2 (0.58) | FPR2FPR1PDE4APDE4BPDE4C | |
| SCHEMBL16785324 | 0.85 | FPR2 (0.58) | FPR2FPR1PDE4APDE4BPDE4C | |
| SCHEMBL20177580 | 0.84 | KDM1A (0.45) | FPR2FPR1KDM1AKDM1B | |
| SCHEMBL20177726 | 0.84 | FPR2 (0.54) | FPR2FPR1PDE4APDE4BPDE4C | |
| SCHEMBL18106521 | 0.81 | FPR2 (0.40) | FPR2FPR1PDE4APDE4BPDE4C | |
| SCHEMBL18579446 | 0.81 | FPR2 (0.40) | FPR2FPR1PDE4APDE4BPDE4C | |
| SCHEMBL19865816 | 0.80 | FPR2 (0.40) | FPR2FPR1PDE4APDE4BPDE4C | |
| SCHEMBL18106584 | 0.80 | FPR2 (0.40) | FPR2FPR1PDE4APDE4BPDE4C | |
| SCHEMBL18106583 | 0.80 | FPR2 (0.40) | FPR2FPR1PDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018092916-A1 | NITROGEN-CONTAINING POLYCYCLIC HETEROCYCLIC DERIVATIVE | 宇部興産株式会社 | 2018-05-24 | — | — | WO | disclosed |